IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
-5.26%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$329M
AUM Growth
+$329M
(-5.9%)
Cap. Flow
+$40M
Cap. Flow
% of AUM
12.16%
Top 10 Holdings %
Top 10 Hldgs %
37.77%
Holding
184
New
15
Increased
124
Reduced
12
Closed
9
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$8.27M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.11M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.52M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$6.34M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$5.94M |
Top Sells
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$11.3M |
| 2 |
Biogen
BIIB
|
$6M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
$5.89M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$3.95M |
| 5 |
iShares Biotechnology ETF
IBB
|
$3.67M |
Sector Composition
| 1 | Healthcare | 98.75% |
| 2 | Consumer Staples | 0.62% |
| 3 | Technology | 0.36% |
| 4 | Financials | 0.23% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBLA
76
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
| $750K | 0.1% |
15
+1
| +7% | +$50K |
|
77
Quantum-Si Incorporated
QSI
$217M
| $736K | 0.1% |
157,363
+12,957
| +9% | +$60.6K |
|
78
NextCure
NXTC
$13.3M
| $686K | 0.09% |
11,755
+584
| +5% | +$34.1K |
|
79
InflaRx
IFRX
$117M
| $639K | 0.08% |
349,468
+18,420
| +6% | +$33.7K |
|
80
Pliant Therapeutics
PLRX
$105M
| $636K | 0.08% |
90,805
+4,093
| +5% | +$28.7K |
|
81
VistaGen Therapeutics
VTGN
$113M
| $633K | 0.08% |
17,040
+1,184
| +7% | +$44K |
|
82
Solid Biosciences
SLDB
$448M
| $625K | 0.08% |
34,744
| – | – |
|
83
Astria Therapeutics
ATXS
$394M
| $619K | 0.08% |
92,223
+4,643
| +5% | +$31.2K |
|
84
Disc Medicine
IRON
$2.14B
| $615K | 0.08% |
14,770
+735
| +5% | +$30.6K |
|
|
TNFA
85
TNF Pharmaceuticals, Inc. Common Stock
TNFA
$615M
| $612K | 0.08% |
44
+3
| +7% | +$41.7K |
|
86
Tenax Therapeutics
TENX
$27.5M
| $596K | 0.08% |
459
+25
| +6% | +$32.5K |
|
87
Relmada Therapeutics
RLMD
$48.8M
| $588K | 0.08% |
21,801
+1,058
| +5% | +$28.5K |
|
88
KalVista Pharmaceuticals
KALV
$713M
| $586K | 0.08% |
39,730
+3,154
| +9% | +$46.5K |
|
89
Cyclerion Therapeutics
CYCN
$7.75M
| $585K | 0.08% |
26,373
+1,242
| +5% | +$27.6K |
|
|
HARP
90
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $582K | 0.08% |
11,701
+572
| +5% | +$28.5K |
|
|
ICPT
91
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $572K | 0.08% |
35,149
+584
| +2% | +$9.5K |
|
92
Avalo Therapeutics
AVTX
$139M
| $554K | 0.07% |
265
+15
| +6% | +$31.4K |
|
93
DiaMedica Therapeutics
DMAC
$274M
| $553K | 0.07% |
221,252
+12,170
| +6% | +$30.4K |
|
94
Mustang Bio
MBIO
$11.1M
| $551K | 0.07% |
729
+54
| +8% | +$40.8K |
|
|
OKUR
95
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
| $546K | 0.07% |
18,560
+1,060
| +6% | +$31.2K |
|
96
vTv Therapeutics
VTVT
$49.4M
| $536K | 0.07% |
18,575
+1,075
| +6% | +$31K |
|
97
Corbus Pharmaceuticals
CRBP
$121M
| $530K | 0.07% |
33,254
+1,636
| +5% | +$26.1K |
|
98
Kodiak Sciences
KOD
$453M
| $526K | 0.07% |
+68,100
| New | +$526K |
|
|
OTIC
99
DELISTED
Otonomy, Inc.
OTIC
| $525K | 0.07% |
218,538
+10,232
| +5% | +$24.6K |
|
100
Assembly Biosciences
ASMB
$183M
| $468K | 0.06% |
18,923
+1,018
| +6% | +$25.2K |
|